Foundation for the NIH Awards 2020 Trailblazer Prize for Clinician-Scientists to Michael Wilson, M.D.
NORTH BETHESDA, Md., Sept. 18, 2020 /PRNewswire/ -- The Foundation for the National Institutes of Health (FNIH) today bestowed its annual Trailblazer Prize for Clinician-Scientists to Michael Wilson, M.D., of the University of California San Francisco (UCSF). Dr. Wilson has received the Trailblazer Prize, along with a $10,000 honorarium, for pioneering a next-generation diagnostic approach to pinpoint infectious causes of inflammatory conditions of the central nervous system. The Trailblazer Prize is made possible by a generous donation from John I. Gallin, M.D., and Elaine Gallin, Ph.D., to the FNIH.
Now in its third year, the Trailblazer Prize recognizes the outstanding contributions of early career clinician-scientists whose research translates basic scientific observations into new paradigm-shifting approaches for diagnosing, preventing, treating or curing disease and disability.
Dr. Wilson is Associate Professor of Neurology in the Division of Neuroimmunology and Glial Biology at the UCSF Weill Institute for Neurosciences. Bypassing the traditional process of differential diagnosis, Wilson employs the innovative technique of metagenomic next-generation sequencing. This approach efficiently analyzes the genetic material in a patient's sample to precisely identify specific infectious agents causing inflammation while also ruling out irrelevant pathogens that might otherwise have been suspected. Wilson has unearthed key knowledge about the infectious and autoimmune causes of inflammatory conditions in the brain, spinal cord and meninges, including major discoveries such as co-identifying the family of viruses behind acute flaccid myelitis, a paralyzing, polio-like condition affecting children. Wilson's lab is currently applying these novel methods to search for an infectious trigger in multiple sclerosis. Dr. Wilson earned his M.D. and M.A.S. from UCSF.
"Dr. Wilson has developed and applied revolutionary new tools to improve the diagnosis of central nervous system infections like meningitis and encephalitis. His groundbreaking work has led to new insights about infectious and autoimmune diseases, with important implications not only for how individual patients are treated, but for a better understanding of the etiology and pathophysiology of these disorders," said Steven M. Paul, M.D., Chairman of the Board, FNIH.
In lieu of an in-person event to celebrate this achievement, the Trailblazer Prize will be bestowed via the Online Celebration of the 2020 FNIH Awards, an interactive website launched today at awards.fnih.org to laud Dr. Wilson and the other recipients of 2020 FNIH honors.
"I feel very fortunate to win this award, which is an incredible honor," said Dr. Wilson. "This is a very meaningful recognition of the work that I've done with a phenomenal group of scientists and clinicians. I am fortunate to get to work in an environment that offers close collaboration between the laboratory and the clinical space, and seeing that recognized means quite a lot."
Dr. Wilson was selected as the 2020 Trailblazer Prize recipient by a jury of distinguished biomedical research leaders, chaired by Michael J. Welsh, M.D., Director, Pappajohn Biomedical Institute, University of Iowa. In addition to Dr. Welsh, other members of the esteemed jury include:
To view the Online Celebration of the 2020 FNIH Awards, please visit awards.fnih.org.
About the Foundation for the National Institutes of Health
SOURCE Foundation for the National Institutes of Health